Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010052917> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3010052917 abstract "Background: Isavuconazole (ISV) is a second-generation triazole antifungal used for invasive fungal infections (IFIs). Here, we describe our experiences of ISV. Methods: This single-centre retrospective study included all patients who commenced a course of ISV over a 3-year period (1/7/16-30/6/19). ISV was used for the treatment of IFIs when no alternative was suitable. Demographics, clinical details and antimicrobial history were obtained from our integrated electronic health record and laboratory system (EPIC). Results: Twenty-four patients, aged between 17–78 years (median 54), received ISV in the study period. Sixteen (67%) were haematology patients. Using EORTC criteria, six had possible invasive aspergillosis (IA), 1 had a possible yeast infection, 13 had probable IA, 3 had proven IA and one had a proven yeast infection. Four were neutropenic (neutrophil count <0.5x109/L) and 7 had renal impairment. Half of the patients (12/24; 50%) had received a transplant prior to commencing (nine allografts, one kidney, one lung, one multi-visceral) and a further two underwent an allograft whilst receiving ISV. ISV pre-dose levels ranged from 1.29–7.7mg/L (median 2.73mg/L; IQR 2.1 – 3.13mg/L). ISV was given for 1–733 days (median 42 days). In patients who were still alive during therapy, the treatment duration ranged from 3–342 days (median 97 days). Ten were dead within 42-84 days of commencing therapy; 6 had died by the end of therapy. Conclusion: Our findings suggest that ISV is used infrequently, predominantly in haematology. More data is needed to determine optimal treatment course and the role of therapeutic drug monitoring." @default.
- W3010052917 created "2020-03-13" @default.
- W3010052917 creator A5006875086 @default.
- W3010052917 creator A5029225296 @default.
- W3010052917 creator A5054628524 @default.
- W3010052917 creator A5078107358 @default.
- W3010052917 date "2020-02-01" @default.
- W3010052917 modified "2023-09-25" @default.
- W3010052917 title "Real-world experience with Isavuconazole therapy in a large tertiary hospital in Cambridge, UK" @default.
- W3010052917 doi "https://doi.org/10.1099/acmi.fis2019.po0093" @default.
- W3010052917 hasPublicationYear "2020" @default.
- W3010052917 type Work @default.
- W3010052917 sameAs 3010052917 @default.
- W3010052917 citedByCount "0" @default.
- W3010052917 crossrefType "journal-article" @default.
- W3010052917 hasAuthorship W3010052917A5006875086 @default.
- W3010052917 hasAuthorship W3010052917A5029225296 @default.
- W3010052917 hasAuthorship W3010052917A5054628524 @default.
- W3010052917 hasAuthorship W3010052917A5078107358 @default.
- W3010052917 hasBestOaLocation W30100529171 @default.
- W3010052917 hasConcept C126322002 @default.
- W3010052917 hasConcept C141071460 @default.
- W3010052917 hasConcept C144024400 @default.
- W3010052917 hasConcept C149923435 @default.
- W3010052917 hasConcept C16005928 @default.
- W3010052917 hasConcept C167135981 @default.
- W3010052917 hasConcept C2778566413 @default.
- W3010052917 hasConcept C2779548794 @default.
- W3010052917 hasConcept C2780084366 @default.
- W3010052917 hasConcept C2780690907 @default.
- W3010052917 hasConcept C501593827 @default.
- W3010052917 hasConcept C71924100 @default.
- W3010052917 hasConcept C81396022 @default.
- W3010052917 hasConcept C86803240 @default.
- W3010052917 hasConcept C89423630 @default.
- W3010052917 hasConceptScore W3010052917C126322002 @default.
- W3010052917 hasConceptScore W3010052917C141071460 @default.
- W3010052917 hasConceptScore W3010052917C144024400 @default.
- W3010052917 hasConceptScore W3010052917C149923435 @default.
- W3010052917 hasConceptScore W3010052917C16005928 @default.
- W3010052917 hasConceptScore W3010052917C167135981 @default.
- W3010052917 hasConceptScore W3010052917C2778566413 @default.
- W3010052917 hasConceptScore W3010052917C2779548794 @default.
- W3010052917 hasConceptScore W3010052917C2780084366 @default.
- W3010052917 hasConceptScore W3010052917C2780690907 @default.
- W3010052917 hasConceptScore W3010052917C501593827 @default.
- W3010052917 hasConceptScore W3010052917C71924100 @default.
- W3010052917 hasConceptScore W3010052917C81396022 @default.
- W3010052917 hasConceptScore W3010052917C86803240 @default.
- W3010052917 hasConceptScore W3010052917C89423630 @default.
- W3010052917 hasLocation W30100529171 @default.
- W3010052917 hasOpenAccess W3010052917 @default.
- W3010052917 hasPrimaryLocation W30100529171 @default.
- W3010052917 hasRelatedWork W11922199 @default.
- W3010052917 hasRelatedWork W13242404 @default.
- W3010052917 hasRelatedWork W13968 @default.
- W3010052917 hasRelatedWork W16266695 @default.
- W3010052917 hasRelatedWork W17239941 @default.
- W3010052917 hasRelatedWork W18544304 @default.
- W3010052917 hasRelatedWork W21288624 @default.
- W3010052917 hasRelatedWork W2812983 @default.
- W3010052917 hasRelatedWork W8808446 @default.
- W3010052917 hasRelatedWork W9894142 @default.
- W3010052917 isParatext "false" @default.
- W3010052917 isRetracted "false" @default.
- W3010052917 magId "3010052917" @default.
- W3010052917 workType "article" @default.